Published in Infect Immun on October 01, 1992
Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev (1998) 4.14
The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev (2000) 2.95
Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev (1993) 1.88
New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol (1999) 1.46
Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryot Cell (2007) 1.29
Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun (2000) 1.29
Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect Immun (1994) 1.26
Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev (2004) 1.22
Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect Immun (1996) 1.13
Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev (1998) 1.12
Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides. Infect Immun (1993) 1.09
A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J Biol Chem (2010) 1.04
The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathog (2013) 0.99
Structural modification of cell wall mannans of Candida albicans serotype A strains grown in yeast extract-Sabouraud liquid medium under acidic conditions. Infect Immun (1994) 0.95
Characterization of epitopes recognized by Candida factor 1 and 9 antisera by use of Saccharomyces cerevisiae mnn mutants. Infect Immun (1993) 0.92
Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis. Infect Immun (2006) 0.90
Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains. Infect Immun (1994) 0.90
Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans. Infect Immun (2000) 0.89
Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype. Infect Immun (2002) 0.89
Minimum chemical requirements for adhesin activity of the acid-stable part of Candida albicans cell wall phosphomannoprotein complex. Infect Immun (1998) 0.87
Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages. Infect Immun (2000) 0.87
Structure of cell wall mannan of Candida kefyr IFO 0586. Infect Immun (1994) 0.83
Comparative Analysis of Protein Glycosylation Pathways in Humans and the Fungal Pathogen Candida albicans. Int J Microbiol (2014) 0.82
Immunochemistry of pathogenic yeast, Candida species, focusing on mannan. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.80
Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans. Clin Diagn Lab Immunol (1997) 0.79
Antigenicity of cell wall mannans of Candida albicans NIH B-792 (serotype B) strain cells cultured at high temperature in yeast extract-containing sabouraud liquid medium. Clin Diagn Lab Immunol (1996) 0.77
Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall. Mol Microbiol (2015) 0.77
Application of novel analytical ultracentrifuge analysis to solutions of fungal mannans. Eur Biophys J (2016) 0.75
Evidence for the presence of immunoglobulin E antibodies specific to the cell wall phosphomannoproteins of Candida albicans in patients with allergies. Clin Diagn Lab Immunol (1996) 0.75
Importance of α- and β/α-linked mannooligosaccharides in antibody response against C. dubliniensis. Glycoconj J (2010) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J Biol Chem (1960) 21.21
Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci U S A (1990) 3.90
Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen. J Cell Biol (1987) 2.13
Serologic aspects on yeast classification. Mycopathol Mycol Appl (1974) 1.80
Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch Biochem Biophys (1989) 1.70
Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science (1985) 1.60
Enhanced detection with an enzyme-linked immunosorbent assay of candida mannan in antibody-containing serum after heat extraction. J Infect Dis (1982) 1.53
Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T. Arch Biochem Biophys (1986) 1.46
Structural study of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues. Arch Biochem Biophys (1990) 1.44
Structural analysis of phospho-D-mannan-protein complexes isolated from yeast and mold form cells of Candida albicans NIH A-207 serotype A strain. Carbohydr Res (1989) 1.44
Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys (1985) 1.35
Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev (1991) 1.32
Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol (1981) 1.31
Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells. Infect Immun (1990) 1.31
Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol (1987) 1.23
Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infect Immun (1985) 1.21
Candida albicans serotype A strains grow in yeast extract-added Sabouraud liquid medium at pH 2.0, elaborating mannans without beta-1,2 linkage and phosphate group. Biochem Biophys Res Commun (1991) 1.19
Isolation of mannan-protein complexes from viable cells of Saccharomyces cerevisiae X2180-1A wild type and Saccharomyces cerevisiae X2180-1 A-5 mutant strains by the action of Zymolyase-60,000. J Bacteriol (1983) 1.18
Relationship between phosphate content and immunochemical properties of subfractions of bakers' yeast mannan. J Bacteriol (1978) 1.17
Antigenic structure of Candida albicans. Immunochemical basis of the serologic specificity of the mannans in yeasts. Immunol Ser (1989) 1.16
Evidence for oligomannosyl residues containing both beta-1,2 and alpha-1,2 linkages as a serotype A-specific epitope(s) in mannans of Candida albicans. Infect Immun (1992) 1.16
A method for the rapid identification of the genus Candida. Mycopathol Mycol Appl (1959) 1.13
Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol (1990) 1.13
The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem (1988) 1.11
Uromodulin. An immunosuppressive 85-kilodalton glycoprotein isolated from human pregnancy urine is a high affinity ligand for recombinant interleukin 1 alpha. J Biol Chem (1986) 1.11
Immunologic significance of diverse specificity of monoclonal antibodies against mannans of Candida albicans. J Immunol (1989) 1.07
IL-2, a lectin with specificity for high mannose glycopeptides. J Immunol (1989) 1.05
Structural study on a phosphorylated mannotetraose obtained from the phosphomannan of Candida albicans NIH B-792 strain by acetolysis. Arch Biochem Biophys (1991) 1.04
Interactions of monospecific antisera with cell surface determinants of Candida albicans. Infect Immun (1988) 1.01
Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Infect Immun (1990) 0.98
Sequential nuclear magnetic resonance assignment of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Biochemistry (1992) 0.96
Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin Chem (1988) 0.96
Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. Proc Natl Acad Sci U S A (1986) 0.94
Reassessment of antigenic determinant of Saccharomyces cerevisiae serotype Ia. Microbiol Immunol (1990) 0.93
Structure of the D-mannan of Candida stellatoidea IFO 1397 strain. Comparison with that of the phospho-D-mannan of Candida albicans NIH B-792 strain. Carbohydr Res (1990) 0.93
Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin Exp Immunol (1982) 0.90
Induction of suppressor cells in vitro by Candida albicans. Cell Immunol (1986) 0.88
Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide. Infect Immun (1984) 0.88
Saccharomyces kluyveri cell wall mannoprotein. Structures of the O- and N-linked carbohydrate components. J Biol Chem (1981) 0.88
Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cell Immunol (1986) 0.87
Studies on detection of Candida antigen in the sera of mice inoculated orally with Candida albicans. Mycopathologia (1988) 0.83
Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites. Arch Surg (1989) 0.80
Sandwich enzyme-linked immunosorbent assay of D-mannans of Candida albicans NIH A-207 and NIH B-792 strains using concanavalin A and polyclonal rabbit anti-C. albicans antisera. Carbohydr Res (1991) 0.79
Immunochemical studies of the mannans of Saccharomyces cerevisiae X2180-1A-5 and Saccharomyces cerevisiae 4484-24D-1 mutant strains, with special reference to their phosphate content. J Bacteriol (1980) 0.78
Antigenic relationship between Candida parapsilosis and Candida albicans serotype B. Microbiol Immunol (1984) 0.78
Quantitative precipitin reaction and enzyme-linked immunosorbent assay of mannans of Candida albicans NIH A-207 and NIH B-792 strains compared. Clin Chem (1988) 0.77
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Engineered GFP as a vital reporter in plants. Curr Biol (1996) 9.03
Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem (1968) 6.28
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem (1968) 5.66
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med (2000) 3.57
Structure and function of signal-transducing GTP-binding proteins. Annu Rev Biochem (1991) 3.48
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
ATP-linked calcium transport in cells and membrane vesicles of Streptococcus faecalis. J Biol Chem (1978) 3.14
Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12
S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell (1990) 3.09
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet (1999) 3.07
Inositol 1,4,5-trisphosphate receptor localized to endoplasmic reticulum in cerebellar Purkinje neurons. Nature (1989) 2.94
Non-invasive quantitative detection and applications of non-toxic, S65T-type green fluorescent protein in living plants. Plant J (1999) 2.88
Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer (1984) 2.78
Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation (2000) 2.78
A proton-translocating ATPase regulates pH of the bacterial cytoplasm. J Biol Chem (1985) 2.71
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
Mechanism of action of globomycin. J Antibiot (Tokyo) (1978) 2.66
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res (2000) 2.61
Regulation of the cytoplasmic pH in Streptococcus faecalis. J Biol Chem (1982) 2.61
Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun (1994) 2.60
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Nucleo-cytoplasmic transport of U snRNPs: definition of a nuclear location signal in the Sm core domain that binds a transport receptor independently of the m3G cap. EMBO J (1993) 2.55
Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol (1998) 2.52
An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med (1977) 2.52
Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke (2001) 2.51
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci U S A (1994) 2.44
Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem (1991) 2.36
Pattern electrical stimulation of the human retina. Vision Res (1999) 2.35
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med (1992) 2.30
Green-fluorescent protein as a new vital marker in plant cells. Plant J (1995) 2.28
Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28
Unique morphology of the human eye. Nature (1997) 2.27
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst (1994) 2.25
Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25
Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25
Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation (1995) 2.24
Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J Physiol (1992) 2.20
DNA methylation as a mechanism of transcriptional regulation in nonphotosynthetic plastids in plant cells. Proc Natl Acad Sci U S A (1988) 2.19
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). Br J Cancer (2008) 2.19
Frequency and stability of chromosomal integration of adenovirus vectors. J Virol (1999) 2.18
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17
Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma (1998) 2.15
Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant (2000) 2.15
Subtotal corpectomy versus laminoplasty for multilevel cervical spondylotic myelopathy: a long-term follow-up study over 10 years. Spine (Phila Pa 1976) (2001) 2.14
New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2005) 2.14
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study. Aliment Pharmacol Ther (2013) 2.13
Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol (1990) 2.09
The number of ribosomal RNA genes in Mycoplasma capricolum. Mol Gen Genet (1981) 2.08
The influence of p-nitrophenyl beta-d-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage. J Biochem (1973) 2.08
Fractal analysis of cerebral blood flow distribution in Alzheimer's disease. J Nucl Med (2001) 2.08
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene (2000) 2.04
Streptococcal cytoplasmic pH is regulated by changes in amount and activity of a proton-translocating ATPase. J Biol Chem (1986) 2.03
Copper proteins and oxygen. Correlations between structure and function of the copper oxidases. J Gen Physiol (1965) 2.02
Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem (1998) 2.02
A putative Ca2+-binding protein: structure of the light subunit of porcine calpain elucidated by molecular cloning and protein sequence analysis. Proc Natl Acad Sci U S A (1985) 1.99
A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta (1985) 1.99
Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron (1996) 1.98
Risk factors for cardiac and pyloric stenosis after endoscopic submucosal dissection, and efficacy of endoscopic balloon dilation treatment. Endoscopy (2009) 1.98
Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol (1992) 1.96
Eyelid reconstruction using a hard palate mucoperiosteal graft combined with a V-Y subcutaneously pedicled flap. Br J Plast Surg (2001) 1.96
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2000) 1.94
An assessment of a method of inflating cuffs with a nitrous oxide gas mixture to prevent an increase in intracuff pressure in five different tracheal tube designs apparatus. Anaesthesia (2001) 1.93
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res (1979) 1.93
Possible relationship of a 36-megadalton Salmonella enteritidis plasmid to virulence in mice. Infect Immun (1985) 1.91
Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke (1995) 1.90
Quantification of picogram levels of specific DNA immobilized in microtiter wells. FEBS Lett (1985) 1.90
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother (1989) 1.90
Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89
Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J Biol Chem (2000) 1.88
Tremorgenic toxins from Aspergillus fumigatus Fres. Chem Pharm Bull (Tokyo) (1971) 1.88
Amplification of the Streptococcus faecalis proton-translocating ATPase by a decrease in cytoplasmic pH. J Bacteriol (1984) 1.87
Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase). Biochem J (1980) 1.86
Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J Biol Chem (1968) 1.86
Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res (1994) 1.84
The incidence of simple renal cyst by computed tomography. Clin Radiol (1983) 1.82
Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res (2000) 1.82
Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.81
Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. Cancer Res (1979) 1.81
Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res (1985) 1.81
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci U S A (1994) 1.78
Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol (1999) 1.77
An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron (1994) 1.77
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene (2000) 1.76
Pressure-dependent metallic and superconducting phases in a germanium artificial metal. Phys Rev Lett (2009) 1.73
Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein. Biochem Biophys Res Commun (1989) 1.73
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
Actions of noradrenaline and acetylcholine on sympathetic ganglion cells. J Physiol (1970) 1.72